# Survey of Inhibitors in Plasma-Product Exposed Toddlers

> **NCT01064284** · PHASE4 · COMPLETED · sponsor: **Fondazione Angelo Bianchi Bonomi** · enrollment: 303 (actual)

## Conditions studied

- Hemophilia A

## Interventions

- **DRUG:** PLASMA DERIVED Factor VIII
- **DRUG:** Recombinant FVIII

## Key facts

- **NCT ID:** NCT01064284
- **Lead sponsor:** Fondazione Angelo Bianchi Bonomi
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2015-05
- **Final completion:** 2015-05
- **Target enrollment:** 303 (ACTUAL)
- **Last updated:** 2017-08-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01064284

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01064284, "Survey of Inhibitors in Plasma-Product Exposed Toddlers". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01064284. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*